In c.421CA subjects, AUCR, V T (Logan), and K 1 were significantly increased in scan 2 as compared with scan 1, whereas V T (2T4K) showed a trend for increases without reaching statistical significance ( P = 0.144) ( Figure 4 , Table 2 ).
More stroma showed a trend of being related to poor DFS in stage II (HR 2.07; 95% CI 0.76–5.60; Log-rank p = 0.144, Additional file 3 : Figure S1a).
Results Subjects receiving VQW-765 showed a trend of improvement in intensity of anxiety, as measured by the SUDS, during the performance phase of a TSST compared with placebo ( P = 0.1443).
G415 cells also showed a trend of reduction in their invasion ability ( p = 0.14466, by t -test) ( Figure 5 b right).
In the analysis of the correlation between Tim-3/Gal-9 expression and patient survival, although high expression of Tim-3 or Gal-9 showed a trend for association with poor survival, there was no significant difference in Tim-3 (P = 0.1448) or Gal-9 (P = 0.1360) expression between patients with poor and patients with good survival.
Responders also showed a trend toward higher pho-tophobia scores at baseline (mean VAS score 61.9) than Nonresponders (mean 41.9; P =0.145).
MET overexpression showed a trend toward improved PFS (HR: 0.77, 95% CI: 0.54–1.09, p = 0.145) ( Figure 3 A).
The difference between the two groups showed a trend towards improvement (P = 0.146).
Documented recurrent AF showed a trend towards lower incidence in the control group compared with the TM group (35% vs 47%; p = 0.146).
Compared to VEH-treated OVX mice, CBD-treated OVX mice showed a trend of lower Il1b ( p = 0.146) and Il6 ( p = 0.124) mRNA levels in ileal tissues ( Figure 2A ) and significantly lower Il1b, Il6 and Tnf in colon tissues ( Figure 2B ).
In contrast, no individual gene expression levels were statistically significant for recurrence prediction, though UHRF1 showed a trend toward increased risk (HR = 1.72, p = 0.146), while FLVCR2 (HR = 0.02, p = 0.079) suggested a protective role.
PBMC comparison showed a trend to greater differences in SCR when the patients were off-ART (p = 0.146) ( Figure 1b ).
Outcomes Patients with a spot sign showed a trend toward longer length of stay in an intensive care unit (10.78 days [SD 11.55] vs. 6.52 days [SD 7.45], p = 0.146) and overall hospital stay (17.83 days [SD 25.27] vs. 10.97 days [SD 13.81], p = 0.274), although neither of these reached significance in this sample.
In U251 cells ( Figure 5 ), the number of invading cells showed a trend toward a decrease in the miR-382-5p mimics group ( P =0.146), and the number of invading cells was significantly increased in the miR-382-5p inhibitors group ( P =0.002).
Immunohistochemistry staining of OSX for osteoprogenitor cells showed a trend of increasing OSX + cells ( p = 0.1461) in the PF04418948-treated group compared to the vehicle-treated group ( Figure 9 C,D).
ERβ status showed a trend of better prognosis, not reaching a statistical significance ( p =0.1463) [ 12 ].
Further analysis of the tumor IHC staining which compared c-myc staining at the invasive front to the inner layer also showed a trend for reduced c-myc expression, with the strongest trend at the invasive front ( p = 0.1465) ( Figure S2A ). 2.2.
1e ), and aging upregulated genes showed a trend towards downregulation by MI ( p = 0.1466, Fig. 1f ).
Results: The Hanna trephine showed a trend towards producing a more circular recipient button than the Barron trephine (ratio of major axis to minor axis), ie, 1.059 ± 0.041 versus 1.110 ± 0.027 ( P = 0.147) and the Hanna punch showed a trend towards producing a more circular donor cut than the Barron punch, ie, 1.021 ± 0.022 versus 1.046 ± 0.039 ( P = 0.445).
hs-CRP median values were 2.20 (IQR, 1.20-7.98) mg/mL, 1.00 (IQR, 0.48-2.50) mg/mL, and 1.20 (IQR, 0.78-2.10) mg/mL, respectively, and showed a trend toward significant differences across the 3 groups ( P = 0.147).
Although self-employed individuals showed a trend toward faster return-to-work (crude HR of 1.38, 95% CI: 0.89–2.13), this was not statistically significant ( P =0.147) (Table 2 ; Appendix B, Supplemental Digital Content 2, http://links.lww.com/BRS/C767 ).
The analysis showed a trend in favor of the LET + ZOL treatment (OR = 1.72; 95% CI, 0.827 to 3.586; P = 0.147).
No significant difference was observed in the other five CC strains between THS exposed and control groups, albeit CC037 showed a trend towards a decrease in memory potential in the THS exposed group ( P = 0.147).
14 Though limited by small numbers, IL-2/SIR/TAC patients who prematurely discontinued IL-2 before day +90 (n=6) actually showed a trend toward less acute GvHD compared to protocol-adherent individuals (n=14) [16.7% (95%CI:0.001–77.7) vs. 50% (95%CI: 27.8–77.1), P =0.1475].
With a median follow-up of 20.27 months (ranging from 0 to 285.2 months), young patients showed a trend toward reduced disease-free survival (DFS) in our center (Fig. 1 D, P = 0.148).